Medicare Enrolled

Dr. Francis Mah, MD

Optician · Pittsburgh, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
203 LOTHROP ST, Pittsburgh, PA 15213
4126472200
In practice since 2006 (20 years)
NPI: 1528032620 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mah

Dr. Francis Mah is an optician specialist in Pittsburgh, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mah performed 1,730 Medicare services across 1,492 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mah received a total of $968,359 from 44 pharmaceutical and/or device companies across 1350 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 18% volume in PA $968,359 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,730
Medicare services
Top 18% in PA for optician
1,492
Unique beneficiaries
$136
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
398 $91 $350
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
289 $457 $2,065
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
255 $30 $136
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
208 $34 $157
CT scan of cornea
A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye.
170 $27 $122
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
167 $70 $248
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
166 $117 $453
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
57 $276 $1,303
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
20 $29 $124
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
16.7% high complexity
25.7% medium
57.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$968,359
Total received (2018-2024)
Avg $138,337/year across 7 years
Top 1% in PA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
1,350
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$599,574 (61.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$359,856 (37.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,928 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$126,809
2023
$109,881
2022
$155,740
2021
$144,170
2020
$139,107
2019
$213,870
2018
$78,781

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb Americas Inc.
$54,192
Oyster Point Pharma, Inc.
$47,389
ANI Pharmaceuticals, Inc.
$6,492
Alcon Vision LLC
$4,747
Alcon Research LLC
$4,000
Amgen Inc.
$2,161
Carl Zeiss Meditec, Inc.
$1,754
Glaukos Corporation
$1,422
Tarsus Pharmaceuticals, Inc.
$1,296
ABBVIE INC.
$1,147
Carl Zeiss Meditec USA, Inc.
$869
SUN PHARMACEUTICAL INDUSTRIES INC.
$639
Dompe US, Inc.
$276
Apellis Pharmaceuticals, Inc.
$132
Mallinckrodt Hospital Products Inc.
$114
Thea Pharma Inc.
$48
PFIZER INC.
$32
BIOTISSUE HOLDINGS INC.
$30
Harrow Eye, LLC
$28
RxSight Inc
$25
Ocular Therapeutix, Inc.
$17
Top 3 companies account for 85.2% of 2024 payments
All-time payments by company (2018-2024) ›
Oyster Point Pharma, Inc.
$142,731
Johnson & Johnson Surgical Vision, Inc.
$98,151
Kala Pharmaceuticals, Inc.
$93,993
Shire North American Group Inc
$88,435
Bausch & Lomb Americas Inc.
$85,876
Novartis Pharmaceuticals Corporation
$67,909
Sun Pharmaceutical Industries Inc.
$66,040
Dompe US, Inc.
$64,214
Allergan, Inc.
$55,121
Mallinckrodt Hospital Products Inc.
$41,020
GlaxoSmithKline, LLC.
$28,439
Alcon Vision LLC
$19,591
ABBVIE INC.
$13,191
Allergan Inc.
$11,242
Bausch & Lomb, a division of Bausch Health US, LLC
$10,459
Carl Zeiss Meditec, Inc.
$9,696
EYEVANCE PHARMACEUTICALS LLC
$7,865
SUN PHARMACEUTICAL INDUSTRIES INC.
$7,462
Alcon Research LLC
$7,129
ANI Pharmaceuticals, Inc.
$6,492
Aerie Pharmaceuticals, Inc.
$6,396
Alcon Laboratories Inc
$6,170
NOVARTIS PHARMACEUTICALS CORPORATION
$5,674
Sight Sciences, Inc.
$5,160
Ocular Therapeutix, Inc.
$4,383
TearLab Corp
$3,100
Omeros Corporation
$2,833
Ivantis, Inc
$2,334
Amgen Inc.
$2,161
Glaukos Corporation
$1,518
Tarsus Pharmaceuticals, Inc.
$1,296
Carl Zeiss Meditec USA, Inc.
$921
VERTEX PHARMACEUTICALS INCORPORATED
$375
RxSight Inc
$252
Thea Pharma Inc.
$244
GLAUKOS CORPORATION
$164
Apellis Pharmaceuticals, Inc.
$132
Horizon Therapeutics plc
$41
PFIZER INC.
$32
BIOTISSUE HOLDINGS INC.
$30
Harrow Eye, LLC
$28
Astellas Pharma US Inc
$23
Eyevance Pharmaceuticals LLC
$22
Mallinckrodt LLC
$13
Top 3 companies account for 34.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ARGOS · ARTEVO 800 · AcrySof · AcrySof IQ PanOptix UV IOL · AcrySof IQ VIVITY · AcrySof IQ VIVITY IOL · BESIVANCE · BIOTRUE · BLENREP · BLINK NUTRITEARS · BromSite (bromfenac ophthalmic solution) 0.075% · CE-marked KXLA system · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · CIRRUS 6000 with AngioPlex · CIRRUS HD-OCT · COMBIGAN · Catalys Laser System · Centurion · Cequa · Clareon · Compact Intuitiv · DAILIES · DEXTENZA · DUREZOL · DURYSTA · ENVISTA · ENVISTA TORIC · EYSUVIS · Flarex · Hydrus · Hydrus Microstent · IACCESS · IC-8 Apthera IOL · ILEVRO · ILUX · INVELTYS · IOLMaster 500 · IOLMaster 700 · IYUZEH · KXL SYSTEM · KXL System · LOTEMAX SM · LUMIGAN · LenSx · MIEBO · NGENUITY · OCUCOAT · OMIDRIA · OMNI · OMNI SURGICAL SYSTEM · OXERVATE · Omidria · Oxervate · PROLENSA · PURIFIED CORTROPHIN GEL · Pataday · Phacofragmentation Accessories · Precision 1 · QUATERA 700 · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · RYZUMVI · ReSure Sealant · Rhopressa · Rocklatan · SCOUTPRO · STELLARIS · STELLARIS ELITE · Simbrinza · Stellaris · Syfovre · Systane · Systane Complete · TEPEZZA · TIVDAK · TORIC · TRAVATAN Z · TYRVAYA · TearCare · TearLab Osmolarity System · Tecnis 1-piece IOL · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · Tecnis Simplicity · Tecnis Symfony IOL · Tecnis Symphony IOL · TobraDex ST · UPLIZNA · VERACITY SURGICAL · VERITAS Vision System · VEVYE · VICTUS · VUITY · VYZULTA · XDEMVY · XEN · XIIDRA · ZERVIATE · ZYLET · enVista Aspire IOL · enVista MX60 IOL · iDose · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (62%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for optician in PA.

Looking for an optician specialist in Pittsburgh?
Compare opticians in the Pittsburgh area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
1,077
Per 100K population
86.8
County median income
$76,393
Nearest hospital
MAGEE WOMENS HOSPITAL OF UPMC HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mah is a clinical cardiology specialist, with above-average Medicare volume (top 18% in PA), with speaking/promotional industry engagement in the top 1% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mah experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mah performed 398 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mah receive payments from pharmaceutical companies?
Yes. Dr. Mah received a total of $968,359 from 44 companies across 1,350 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mah's costs compare to other opticians in Pittsburgh?
Dr. Mah's average Medicare payment per service is $136. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →